| Heart failure: a growing public health problem. | |
| | |
MedLine Citation:
|
PMID: 7852915 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
At a time when deaths from coronary heart disease and stroke are markedly declining, mortality from heart failure is increasing. Heart failure is a costly and devastating disease, and throughout much of the industrialized world, escalating health-care costs constitute a serious burden on both public and private systems of financing health care, and about one-third of all heart failure patients are admitted to hospital each year. Both prevalance and incidence of heart failure increase steeply with increasing age. The prevalence rate is about 1% at the age of 50, whilst at the age of 80 and above, almost one out of 10 persons will suffer from heart failure. Until recently, the goals for heart failure treatment were to relieve symptoms and enhance functional capacity. Recently, some large scale studies have shown that ACE inhibitors can reduce mortality, prevent development of heart failure, avoid the need for hospitalization and improve prognosis. ACE inhibitors may therefore have promising effects both on patients and on society. A challenge for the future must be early recognition and timely and adequate treatment of heart failure. Such a strategy might have great economic benefits as far as public health is concerned. However, the most rewarding efforts for the population will be to prevent the underlying causes of coronary heart failure as well as risk factors for heart failure. This review will study the magnitude of heart failure as a growing public health problem, the underlying causes, risk factors and treatment. |
| | |
Authors:
|
H Eriksson |
Related Documents
:
|
2981465 - New positive inotropic drugs for the treatment of congestive heart failure. 1691355 - Long-term clinical, hemodynamic, angiographic, and neurohumoral responses to vasodilati... 10903655 - Do patients with suspected heart failure and preserved left ventricular systolic functi... 16250855 - The renin-angiotensin systems: evolving pharmacological perspectives for cerebroprotect... 21861145 - Call for a sudden cardiac death registry: should reporting of sudden cardiac death be m... 2468975 - Prevention of reinfarction subsequent to non-q-wave infarction. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Journal of internal medicine Volume: 237 ISSN: 0954-6820 ISO Abbreviation: J. Intern. Med. Publication Date: 1995 Feb |
Date Detail:
|
Created Date: 1995-03-14 Completed Date: 1995-03-14 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8904841 Medline TA: J Intern Med Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 135-41 Citation Subset: IM |
Affiliation:
|
University of Göteborg, Department of Medicine, Ostra Hospital, Sweden. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angiotensin-Converting Enzyme Inhibitors
/
therapeutic use Heart Failure* / diagnosis, drug therapy, economics, epidemiology, etiology Humans Incidence Prevalence Risk Factors Socioeconomic Factors Sweden / epidemiology |
| Chemical | |
Reg. No./Substance:
|
0/Angiotensin-Converting Enzyme Inhibitors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Brain repair.
Next Document: The putative role of alpha-1-antitrypsin in the disaggregation of amyloid lambda fibrils.